Navigation Links
MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
Date:5/12/2008

the quarter ended March 31, 2008 were $6.1 million, compared to total operating expenses of $4.0 million in the comparable period for 2007. The increase in operating expenses is attributable to continued business growth.

For the quarter ended march 31, 2008, net loss was $3.8 million, or $0.10 per share, compared to a net loss of $3.2 million, or $0.08 per share, for the same period in 2007. Net loss per share for the quarter ended march 31, 2008 was based on weighted average of 38,846,986 shares outstanding, compared to a weighted average of 38,900,383 shares outstanding for the comparable period in 2007.

As of March 31, 2008, cash, cash equivalents and marketable securities were $84.0 million compared to $94.6 million at December 31, 2007. The decrease in cash balance is primarily attributable to the Company's repurchase of its common stock MGT Capital investments and the purchase of shares in Medicsight PLC.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a leading developer of computer-aided detection (CAD) software solutions. Medicsight's CAD solutions help clinicians utilizing Computed Tomography (CT) scans to identify, measure and analyze suspicious pathology within the colon and lungs. The Medicsight CAD products are validated against one of the world's largest databases of verified CT scan data collected from leading healthcare institutions from around the world. Medicsight products allow radiologists and physicians to review scans more quickly and accurately -- saving both time and lives.

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. T
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
2. Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
3. SPO Medical Retains American Capital Ventures for Investor Relations Services
4. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
5. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
6. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
7. RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner
8. Biotech Avoids Fall Out From Tough Quarter for Capital Markets
9. Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Pharmasset Receives $10 Million of Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...stCall/ -- AstraZeneca (NYSE:,AZN) today announced...has,approved once-daily SEROQUEL XR(R) (quetiapine...treatment of the depressive episodes associated wi...associated with bipolar I,disorder, and the mainte...e,therapy to lithium or divalproex. SEROQUEL XR is...
(Date:10/10/2008)... - Neptune Technologies &,Bioressources Inc. ("Nep...inancial results for the fiscal 2009 first quarter...ree-month period ended August 31, 2008 was,$2,366,...nded August 31,2007, representing an increase of ...et loss by 43% to $599,000, or,$0.016 per share, f...
(Date:10/9/2008)...ical tools coming on line at the Spallation Neutro...art neutron science facility at Oak Ridge National...ear physics studies. , The Fundamental Neutron P...receive neutrons for the first time. Among the nuc...beam line are experiments that probe the neutron-r...
(Date:10/9/2008)...Millennium: The Takeda,Oncology Company today anno...utical companies in the world, according to Scienc... biotechnology, biopharmaceutical,pharmaceutical ...hth, the,Company is in the top ten for the first t... http://www.newscom.com/cgi-bin/prnh/20080827/NEW...
Breaking Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9Neptune Technologies & Bioressources Inc. reports first quarter results 2Spallation Neutron Source sends first neutrons to 'Big Bang' beam line 2Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine 2
... Beyond giddy was the mood in Silicon Valley as...,s $1.65 billion acquisition of their "brain chil...b 2.0 phenomena, has well over 34 million unique v...site, viewing over 100 million videos and uploadin...ideo, the Evolution of Dance , has been viewed ov...
... Editor,s note: This is the second in a series of...technology or biotechnology realm. The first edit...ellectual property. , , Madison, Wis. - So now... a copyrightable technology, either one of which c...a business entity, we will discuss how you pick yo...
... The reviews are in for DEMOfall 2006 and - to p...ike us." But amid the compliments (thank you very ...the companies debuted "features" rather than produ...the technologies on the DEMO stage. Yet I suspect ...feature, one might argue, does not a company make....
... Madison, Wis . - On a visit to the University o...irch Bayh said the landmark patent law that bears ...derstand the context in which it was passed. , ,Ba...ecture at the UW-Madison Law School , was in Madi...Act , which gave universities the right to patent ...
Other Biology Technology:Lights, cameras, action: The state of online video 2Lights, cameras, action: The state of online video 3Lights, cameras, action: The state of online video 4Lights, cameras, action: The state of online video 5Lights, cameras, action: The state of online video 6Early Stage Step 2: Choosing a domain name 2Early Stage Step 2: Choosing a domain name 3Early Stage Step 2: Choosing a domain name 4Sometimes, features can make a company 2Sometimes, features can make a company 3Landmark patent law under attack, Bayh says 2Landmark patent law under attack, Bayh says 3
(Date:10/9/2008)...e IOF World Congress on Osteoporosis 2008, at grea...ber 31, 2008. , To benefit from lower rates and...nehealth.org/wco/2008/homepage.html . Special reg... non-OECD countries and for IOF members. After Oct... rates, will be possible. , Your chance to hear...
(Date:10/9/2008)...lecular Biology Laboratory (EMBL) have generated a...elopmental blueprint of a vertebrate. With a newly...st time track all cells for the first 24 hours in ...d into a three-dimensional, digital representation...t online issue of Science , grants many new insig...
(Date:10/9/2008)...or life in higher animals, vitamin D, once linked ...osis, is now recognized as a major player in contr...erside,s Anthony Norman , an international expert...ust issue of the American Journal of Clinical Nu... for contributions to good health in the adaptive ...
(Date:10/9/2008)...earch is a cornerstone of Frontiers in Optics 2008...iety (OSA), being held Oct. 19-23 at the Riverside...ll take place alongside Laser Science XXIV, the an...vision of Laser Science. , Reporters interested ...contact Colleen Morrison at 202.416.1437, cmorri@...
Breaking Biology News(10 mins):Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 3Where optics meets medicine 2Where optics meets medicine 3Where optics meets medicine 4Where optics meets medicine 5Where optics meets medicine 6Where optics meets medicine 7Renovated New Orleans Care Facility Reopens Reuniting Residents and Staff 1365 1Renovated New Orleans Care Facility Reopens Reuniting Residents and Staff 1365 2Renovated New Orleans Care Facility Reopens Reuniting Residents and Staff 1365 3The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 616 1The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 616 2The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 616 3Terumo Heart Reports Summary of DuraHeart 28TM 29 LVAS Clinical Trial Results 282 1Terumo Heart Reports Summary of DuraHeart 28TM 29 LVAS Clinical Trial Results 282 2Last chance for media to register for ECCO 14 the European Cancer Conference 417 1Last chance for media to register for ECCO 14 the European Cancer Conference 417 2Last chance for media to register for ECCO 14 the European Cancer Conference 417 3
...he difficulty of developing an AIDS vaccine, UCLA ...ms in two HIV-positive identical twins responded t...he Dec. 5 issue of the peer-reviewed Journal of Vi...hat the body,s defenses against the virus are rand...archers followed the cases of male twins who were ...
...in the United States by spending less money on mak...existing treatments to the patients who need them,...onwealth University family medicine and public hea...the National Institutes of Health to develop block...ure that Americans actually receive them," said St...
...ncerted effort to catalogue all the molecular comp...es and ions to the genetic code. , These ,parts l...late living processes. By combining models of simp...y represent how entire biological systems - be the...work. As well as contributing to the understanding...
...ty of Texas Medical Branch at Galveston (UTMB) hav...the hepatitis C virus and liver cancer. , The mole...he human papilloma virus (HPV), the cause of genit...anley M. Lemon, the senior author of a paper on th...e online early edition of the Proceedings of the N...
Other Biology News:UCLA scientists discover immune response to HIV differs, even in identical twins 2Access to existing medical treatments could save more lives than spending to improve the treatments 2Access to existing medical treatments could save more lives than spending to improve the treatments 3Setting the standard for computer models of life 2Texas scientists discover how a hepatitis C protein promotes liver cancer 2
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,704-5) or contact custom
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR
... heterologous protein expression in the Drosophil...derived from a primary culture of late stage (20-2.... This versatile cell line grows rapidly at room ...uspension culture. S2 cells are available frozen ...
Biology Products: